Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic peptides specific to BCMA and TACI antigens

Immunogenic peptides specific to BCMA and TACI antigens

US Patent 11517591 · Granted Dec 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T cell receptors specific to b-cell maturation antigen for treatment of cancer2025
Modulating gabarap to modulate immunogenic cell death2024
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
Methods for modulating regulatory T cells, regulatory b cells, and immune respon2024
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
USP7 inhibitors for treating multiple myeloma2022
Inhibitors of histone deacetylase2022
Compounds for the degradation of STK4 and treatment of hematologic malignancies2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32022
XBP1, CD138, and CS1 peptides2021